Global Perspectives on Advanced Squamous Cell Carcinoma of the Head and Neck

Global clinical experts discuss perspectives on current treatment strategies and emerging therapies in advanced squamous cell carcinoma of the head and neck

October 26, 2022

FACULTY CHAIR

Ezra Cohen, MD

UC San Diego Health

Faculty Members

Andreas Dietz, MD, PhD
University Hospital of Leipzig

Kevin Harrington, BSc, MBBS, MRCP, FRCR, FRCP, PhD, DIC
The Institute of Cancer Research

Robert Ferris, MD, PhD
UPMC Hillman Cancer Center

Maura Gillison, MD, PhD
MD Anderson Cancer Center

Tanguy Seiwert , MD
John Hopkins School of Medicine

Agenda

Download the meeting agenda

View Agenda

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Current Immune-Based Approaches
  • Immune Checkpoint Inhibitors: Relapsed/Metastatic
  • Immune Checkpoint Therapy Optimization
  • Targeted Therapies, Alone or in Combination
  • Other Approaches (including investigational IOs)

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.